(Q44252300)

1 December 2017

0 references

Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis (English)

1 reference

1 December 2017

1 reference

Harry R Sumnall

1

1 reference

1 December 2017

Jon C Cole

series ordinal

2

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

Journal of Psychopharmacology

1 December 2017

published in

1 reference

1 December 2017

volume

19

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

84-92

1 reference

Perceived functions predict intensity of use and problems in young polysubstance users.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Subjective reports on the effects of the MDMA ('ecstasy') experience in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

21 January 2018

The BDI of the beholder

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Altered states: the clinical effects of Ecstasy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

The content of ecstasy tablets: implications for the study of their long-term effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Personality dimensions and psychopathological profiles of Ecstasy users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

A contextual profile of club drug use among adults in Chicago

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

MDMA: fact and fallacy, and the need to increase knowledge in both the scientific and popular press

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Construct validation of the hospital anxiety and depression scale with clinical populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

The relation between alcohol problems and the anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Depression in patients with cardiac disease: a practical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Mental disorders in ecstasy users: a prospective-longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Ecstasy (MDMA): a review of its possible persistent psychological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Relationship between ecstasy use and depression: a study controlling for poly-drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Potential human neurotoxicity of MDMA ('Ecstasy'): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Psychosocial profiles of older adolescent MDMA users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

A behavioural economic analysis of alcohol, amphetamine, cocaine and ecstasy purchases by polysubstance misusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Self-reported psychopathology in polydrug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Specific memory deficits in ecstasy users? The results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Cognitive performance and serotonergic function in users of ecstasy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

Impaired executive function in male MDMA ("ecstasy") users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105048901

21 January 2018

Identifiers

DOI

10.1177/0269881105048901

1 reference

1 December 2017

1 reference